Diagnostic Reagents Market Size, Share & Analysis Report, 2022-2030
According to Nova one advisor, the global Diagnostic Reagents market was valued at USD 45.18 billion in 2021 and it is expected to hit around USD 87.4 billion by 2030 with a CAGR of 7.5% during the forecast period 2022 to 2030.
Diagnostics are the mainstay of detection, diagnosis, and assessment of any type of disease. More than 60% to 70% of medical decisions regarding disease treatment, management, and prevention are based on diagnostics. Diagnostics play a key role in preventive healthcare.
Diagnostics deliver information that can benefit patients by enabling the selection of the right treatment. They enable health professionals to choose appropriate preventive interventions and provide vital prognostic data that can optimize care pathways and management. In diagnostic testing, diagnostic reagents play a major role in medical labs, helping produce test results through diagnostic testing assays. Clinical diagnostic reagents are the most basic reagents. They use one or two reagent systems. These could be used for various tests including measuring serum albumin concentrations.
Report Scope of the Diagnostic Reagents Market
|
Report Coverage |
Details |
|
Market Size |
USD 87.4 Billion by 2030 |
|
Growth Rate |
CAGR of 7.5% from 2022 to 2030 |
|
Largest Market |
North America |
|
Fastest Growing Market |
Asia Pacific |
|
Base Year |
2021 |
|
Forecast Period |
2022 to 2030 |
|
Segments Covered |
Product Type, End-user, and Region, |
|
Companies Mentioned |
Abbott Laboratories, Becton, Dickinson and Company, Siemens Healthineers AG, F. Hoffmann-La Roche AG, DiaSorin S.p.A., Sysmex Corporation, bioMerieux SA, Ortho Clinical Diagnostics, Thermo Fisher Scientific, Inc., and Agilent Technologies, Inc. |
High Prevalence and Increase in Incidence of Chronic Infectious Diseases to Boost Demand for Diagnostics
Diagnosis of infectious and chronic diseases is one of the leading applications of in vitro diagnostics reagents. Diagnostic reagents (both biological and chemical reagents) are an integral and vital part of any diagnostic test. Emergence and outbreak of various infectious diseases have created challenges and new opportunities for researchers to develop new diagnostic tools and tests for early diagnosis and prevention of diseases, and IVD reagents play a crucial role in it.
On March 11, 2020, the WHO declared the novel coronavirus (COVID-19) outbreak a global pandemic. Outbreak of new diseases such as COVID 19 and rise in demand for quick and better diagnosis of infectious diseases through in vitro diagnostics are likely to boost the demand for diagnostic reagents, especially IVD reagents, in the market.
Lack of Development of Good Quality Reagents to Affect Small Players
Laboratory development test could become more common as we move toward new technologies and new approaches to clinical testing such as mass spectrometry. Researchers have characterized the effects of poor quality reagents in development of tests for diagnosis of diseases. Here, the importance of being able to trust the quality of reagents is amplified significantly.
Even within regulated markets, we cannot always be sure of ongoing quality; a quick search of the U.S. FDA Medical Device Recalls database shows multiple reagent recalls every year. This makes the pathway of small-scale diagnostic reagent manufacturers quite different to maintain the strict regulatory quality for reagents in the diagnostic reagents facility due to requirement of large capital investment to maintain the stock. Hence, they are unable to cater to the big diagnostic players who always look for good quality reagents.
Availability of Advanced Diagnostic Services Driving Hospitals & Diagnostic Laboratories Segment
In terms of end-user, the global diagnostic reagents market has been divided into hospitals & diagnostic laboratories, academic & research institutes, and others. Rise in number of hospitals with diagnostic labs in developing countries, increase in patient preference to visit hospitals for reimbursement facilities, availability of advanced diagnostic services, and ability to perform various types of tests are expected to drive the hospitals & diagnostic laboratories segment during the forecast period. As of February 2019, there were a total of 33,000 hospitals in China, an increase of 1,866 compared to the same period in 2018.
Regional Outlook of Global Diagnostic Reagents Market
North America accounted for a prominent share of the global diagnostic reagents market in 2021. The trend is projected to continue during the forecast period due to the rise in healthcare care spending for prevention of diseases, adoption of quick innovative tests, and high degree of awareness about routine tests to maintain healthy life in the region.
The diagnostic reagents market in Asia Pacific is anticipated to grow at a high CAGR from 2022 to 2030. This can be ascribed to the increase in popularity of molecular test over traditional tests such as microbiology test, surge in incidence of lifestyle-related & chronic illnesses, and technical developments in countries such as India, Indonesia, Thailand, and South Korea.
Some of the prominent players in the Diagnostic Reagents Market include:
Segments Covered in the Report
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Diagnostic Reagents market
By Geography
Key Benefits for Stakeholders
Chapter 1. Introduction
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Diagnostic Reagents Market
4. Market Overview
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Global Diagnostic Reagents Market Analysis and Forecast, 2017–2030
4.3.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. List of Mostly Used Diagnostic Reagents
5.2. Key Industry Development
5.3. COVID-19 Impact Analysis
6. Global Diagnostic Reagents Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2017–2030
6.3.1. Chromatography Reagents
6.3.2. Molecular Diagnostic Reagents
6.3.3. Immunoassay Reagents
6.3.4. Clinical Chemistry Reagents
6.3.5. Flow Cytometry Reagents
6.3.6. Cell & Tissue Culture Reagents
6.3.7. Hematology & Hemostasis Reagents
6.3.8. Microbiology Reagents
6.3.9. Others
6.4. Market Attractiveness Analysis, by Product
7. Global Diagnostic Reagents Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by End-user, 2017–2030
7.3.1. Hospitals & Diagnostics Laboratories
7.3.2. Academic & Research Institutes
7.3.3. Others
7.4. Market Attractiveness Analysis, by End-user
8. Global Diagnostic Reagents Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region/Country
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Diagnostic Reagents Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Product, 2017–2030
9.2.1. Chromatography Reagents
9.2.2. Molecular Diagnostic Reagents
9.2.3. Immunoassay Reagents
9.2.4. Clinical Chemistry Reagents
9.2.5. Flow Cytometry Reagents
9.2.6. Cell & Tissue Culture Reagents
9.2.7. Hematology & Hemostasis Reagents
9.2.8. Microbiology Reagents
9.2.9. Others
9.3. Market Value Forecast, by End-user, 2017–2030
9.3.1. Hospitals & Diagnostics Laboratories
9.3.2. Academic & Research Institutes
9.3.3. Others
9.4. Market Value Forecast, by Country, 2017–2030
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By End-user
9.5.3. By Country
10. Europe Diagnostic Reagents Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2017–2030
10.2.1. Chromatography Reagents
10.2.2. Molecular Diagnostic Reagents
10.2.3. Immunoassay Reagents
10.2.4. Clinical Chemistry Reagents
10.2.5. Flow Cytometry Reagents
10.2.6. Cell & Tissue Culture Reagents
10.2.7. Hematology & Hemostasis Reagents
10.2.8. Microbiology Reagents
10.2.9. Others
10.3. Market Value Forecast, by End-user, 2017–2030
10.3.1. Hospitals & Diagnostics Laboratories
10.3.2. Academic & Research Institutes
10.3.3. Others
10.4. Market Value Forecast, by Country/Sub-region, 2017–2030
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Product
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Diagnostic Reagents Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017–2030
11.2.1. Chromatography Reagents
11.2.2. Molecular Diagnostic Reagents
11.2.3. Immunoassay Reagents
11.2.4. Clinical Chemistry Reagents
11.2.5. Flow Cytometry Reagents
11.2.6. Cell & Tissue Culture Reagents
11.2.7. Hematology & Hemostasis Reagents
11.2.8. Microbiology Reagents
11.2.9. Others
11.3. Market Value Forecast, by End-user, 2017–2030
11.3.1. Hospitals & Diagnostics Laboratories
11.3.2. Academic & Research Institutes
11.3.3. Others
11.4. Market Value Forecast, by Country/Sub-region, 2017–2030
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Diagnostic Reagents Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017–2030
12.2.1. Chromatography Reagents
12.2.2. Molecular Diagnostic Reagents
12.2.3. Immunoassay Reagents
12.2.4. Clinical Chemistry Reagents
12.2.5. Flow Cytometry Reagents
12.2.6. Cell & Tissue Culture Reagents
12.2.7. Hematology & Hemostasis Reagents
12.2.8. Microbiology Reagents
12.2.9. Others
12.3. Market Value Forecast, by End-user, 2017–2030
12.3.1. Hospitals & Diagnostics Laboratories
12.3.2. Academic & Research Institutes
12.3.3. Others
12.4. Market Value Forecast, by Country/Sub-region, 2017–2030
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Diagnostic Reagents Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017–2030
13.2.1. Chromatography Reagents
13.2.2. Molecular Diagnostic Reagents
13.2.3. Immunoassay Reagents
13.2.4. Clinical Chemistry Reagents
13.2.5. Flow Cytometry Reagents
13.2.6. Cell & Tissue Culture Reagents
13.2.7. Hematology & Hemostasis Reagents
13.2.8. Microbiology Reagents
13.2.9. Others
13.3. Market Value Forecast, by End-user, 2017–2030
13.3.1. Hospitals & Diagnostics Laboratories
13.3.2. Academic & Research Institutes
13.3.3. Others
13.4. Market Value Forecast, by Country/Sub-region, 2017–2030
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Product
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Global & India IVD Reagents Market Analysis and Forecast, by Chemical Type
14.1. Market Value Forecast, by Chemical Type, 2017–2030
14.1.1. Bio-chemical
14.1.2. Immunochemical
14.2. Value Chain Analysis
14.3. Market Value Forecast, India & Global
14.4. Key Trends
14.5. Winning Imperative and Key Entry Barriers
14.6. Regulatory Requirements
14.7. List of Global and Indian Players
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Company Market Share (2021)
15.3. Company Profiles
15.3.1. Abbott Laboratories
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. BD
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. F. Hoffmann-La Roche AG
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. Siemens Healthineers AG
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. DiaSorin S.p.A
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Sysmex Corporation
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. bioMerieux SA
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. Ortho Clinical Diagnostics
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
15.3.9. Thermo Fisher Scientific, Inc.
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. Financial Overview
15.3.9.4. SWOT Analysis
15.3.9.5. Strategic Overview
15.3.10. Agilent Technologies, Inc.
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Product Portfolio
15.3.10.3. Financial Overview
15.3.10.4. SWOT Analysis
15.3.10.5. Strategic Overview
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers